Arcus Biosciences (RCUS) Cash from Operations (2017 - 2026)

Arcus Biosciences' Cash from Operations history runs 10 years deep, the most recent figure standing at 138000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 4.55% year-over-year to 138000000.0; the TTM figure through Mar 2026 stood at 488000000.0 (down 62.67% YoY), while the FY2025 annual figure was 482000000.0, down 183.53% from the prior year.
• Cash from Operations was 138000000.0 for Q1 2026 at Arcus Biosciences, down from 120000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 654000000.0 in Q1 2022 to a low of 138000000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 38705882.35 across 5 years, with a median of 88000000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations soared 1086.19% in 2022, then tumbled 6500.0% in 2025.
• A 5-year view of Cash from Operations shows it stood at 70000000.0 in 2022, then decreased by 25.71% to 88000000.0 in 2023, then slipped by 13.64% to 100000000.0 in 2024, then dropped by 20.0% to 120000000.0 in 2025, then retreated by 15.0% to 138000000.0 in 2026.
• The last three Cash from Operations figures came in at 138000000.0 (Q1 2026), 120000000.0 (Q4 2025), and 97000000.0 (Q3 2025), per Business Quant data.